{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T12:06:11Z","timestamp":1649160371959},"reference-count":24,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2016.00196","type":"journal-article","created":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T05:22:53Z","timestamp":1478496173000},"update-policy":"http:\/\/dx.doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device"],"prefix":"10.3389","volume":"7","author":[{"given":"Slaven","family":"Pikija","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Gschwandtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"R\u00f6sler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Schlick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Greil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Sellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","author":"Arnold","year":"2016","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1200\/JCO.2009.27.4860","article-title":"Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study","volume":"28","author":"Douillard","year":"2010","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clcc.2015.10.002","article-title":"Metastatic colorectal cancer: a systematic review of the value of current therapies","volume":"15","author":"Goldstein","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/OTT.S31412","article-title":"Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer","volume":"5","author":"Fuloria","year":"2012","journal-title":"Onco Targets Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1517\/14740338.2016.1167186","article-title":"The safety of monoclonal antibodies for treatment of colorectal cancer","volume":"15","author":"Berger","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"B6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0025-6196(11)61533-4","article-title":"Complications after unintentional intra-arterial injection of drugs: risks, outcomes, and management strategies","volume":"80","author":"Sen","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/ecc.12008","article-title":"Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation","volume":"22","author":"Garajova","year":"2013","journal-title":"Eur J Cancer Care (Engl)"},{"key":"B8","first-page":"335","article-title":"Embolic stroke secondary to an indwelling catheter in a patient with a patent foramen ovale: a case report and review of the literature","volume":"10","author":"Ahn","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/ans.13789","article-title":"Incidence of pulmonary embolism in patients with newly diagnosed colorectal cancer","author":"Daniel","year":"2016","journal-title":"ANZ J Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"739428","DOI":"10.1155\/2012\/739428","article-title":"Central role of the EGF receptor in neurometabolic aging","volume":"2012","author":"Siddiqui","year":"2012","journal-title":"Int J Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1517\/17425255.2015.1112787","article-title":"Pharmacokinetic and pharmacodynamic evaluation of panitumumab in the treatment of colorectal cancer","volume":"11","author":"Lo","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1593\/neo.09230","article-title":"The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases","volume":"11","author":"Pillay","year":"2009","journal-title":"Neoplasia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1212\/01.WNL.0000068335.01620.9D","article-title":"The clinical features of 16 cases of stroke associated with administration of IVIg","volume":"60","author":"Caress","year":"2003","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1212\/CPJ.0000000000000220","article-title":"Tocilizumab-associated multifocal cerebral thrombotic microangiopathy","volume":"6","author":"Jewell","year":"2016","journal-title":"Neurol Clin Pract"},{"key":"B15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11912-014-0383-3","article-title":"Posterior reversible encephalopathy syndrome: a neurologic phenomenon in cancer patients","volume":"16","author":"Le","year":"2014","journal-title":"Curr Oncol Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1634\/theoncologist.2014-0149","article-title":"Posterior reversible encephalopathy syndrome in patients with cancer","volume":"20","author":"Singer","year":"2015","journal-title":"Oncologist"},{"key":"B17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11060-016-2078-0","article-title":"Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study","volume":"128","author":"Kamiya-Matsuoka","year":"2016","journal-title":"J Neurooncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"306983","DOI":"10.1155\/2013\/306983","article-title":"Posterior reversible encephalopathy syndrome associated with FOLFOX chemotherapy","volume":"2013","author":"Porcello Marrone","year":"2013","journal-title":"Case Rep Oncol Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/NRL.0b013e3182173655","article-title":"Nonconvulsive status epilepticus related to posterior reversible leukoencephalopathy syndrome induced by cetuximab","volume":"17","author":"Palma","year":"2011","journal-title":"Neurologist"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.2146\/ajhp110637","article-title":"Seizure activity during cetuximab infusion in a patient with metastatic colorectal cancer","volume":"69","author":"McClellan","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"B21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00415-011-6152-4","article-title":"The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study","volume":"259","author":"Liman","year":"2012","journal-title":"J Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1007\/s13277-014-2983-9","article-title":"Electrolyte disorders assessment in solid tumor patients treated with anti-EGFR monoclonal antibodies: a pooled analysis of 25 randomized clinical trials","volume":"36","author":"Wang","year":"2015","journal-title":"Tumour Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.neurol.2016.06.004","article-title":"Posterior reversible encephalopathy syndrome (PRES) and hypomagnesemia: a frequent association?","volume":"172","author":"Chardain","year":"2016","journal-title":"Rev Neurol (Paris)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/B978-0-7020-4086-3.00023-0","article-title":"Neurologic complications of electrolyte disturbances and acid-base balance","volume":"119","author":"Espay","year":"2014","journal-title":"Handb Clin Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2016.00196\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T05:22:53Z","timestamp":1478496173000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2016.00196\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,7]]},"references-count":24,"URL":"https:\/\/doi.org\/10.3389\/fneur.2016.00196","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,7]]}}}